Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 541 of 1,261
  1. US 10092598

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    RegenLab USA LLC · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  2. US 10092593

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  3. US 10092538

    Suppositories comprising cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  4. US 10087172

    Compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  5. US 10087169

    Bicyclic PKM2 activators

    Agios Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  6. US 10087143

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  7. US 10087156

    Methods and compositions related to retinoid receptor-selective pathway

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  8. US 10087148

    Quinazolines as biogenic amine transport modulators

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  9. US 10086091

    Method of preparation of biodegradable nanoparticles with recognition characteristics

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  10. US 10086105

    Chitosan foam medical devices and methods

    Providence Health System—Oregon · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  11. US 10086086

    Payload molecule delivery using molecular rebar

    MOLECULAR REBAR DESIGN, LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  12. US 10086041

    Syndecan-4 proteoliposomes for enhanced cutaneous wound healing and minimized inflammatory immune response

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  13. US 10086088

    Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  14. US 10086084

    Activated polyoxazolines and conjugates and compositions comprising the same

    Serina Therapeutics, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  15. US 10085968

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  16. US 10085951

    Curcuminoid formulations and related methods of treatment

    DESIGNS FOR HEALTH, INC. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  17. US 10087150

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  18. US 10085964

    Ultrapure tetrahydrocannabinol-11-oic acids

    Corbus Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  19. US 10085935

    Bee venom composition with effects of protecting and beautifying lip

    SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY, CHINESE ACADEMY OF SCIENCES · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  20. US 10085986

    Pyrimidinone compounds and their use

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  21. US 10085997

    Method of treating microbial infections

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  22. US 10085998

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  23. US 10085990

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  24. US 10086008

    Topical antifungal compositions and methods of use thereof

    REVOLUTION PHARMA LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.